Article
Landmark Study Shows Antibody Therapy Controls 92% of Severe Asthma Cases
Rating:
0.0
Views:
35
Likes:
1
Library:
1
Safer relief for people suffering from severe asthma is a step closer with a large clinical trial finding a monocolonal antibody treatment called benralizumab can radically reduce the need for more dangerous high-dose steroid treatments.
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value